GIV Antibody

About the Target

GIV (G-protein signalling modulator) is a critical non-receptor guanine nucleotide exchange factor (GEF) that modulates G protein-coupled receptor (GPCR) signalling by activating Gαi subunits. It comprises an N-terminal domain that interacts with the epidermal growth factor receptor (EGFR) and a C-terminal GEF domain that activates Gαi, thereby influencing various cellular processes. Depending on the literature source, GIV may also be discussed as Girdin.

Reported cellular context includes cell membrane, cell projection, cytoplasm, and cytoplasmic vesicle, which can matter when signal is compared across treatments or changing cell states. Following GIV across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

GIV is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cell projection, and cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane, cell projection, and cytoplasm across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for GIV. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in GIV reflect biology rather than handling. When interpreting GIV, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep GIV trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.